SXTC — CHINA SXT PHARMACEUTICALS INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
SXTC FAQ
What is SXTC's P/E ratio?
CHINA SXT PHARMACEUTICALS INC (SXTC) currently trades at a P/E ratio of 3.05.
What is SXTC's ROE?
CHINA SXT PHARMACEUTICALS INC reports a Return on Equity (ROE) of 1.96%.
What is SXTC's dividend yield?
CHINA SXT PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is SXTC's Deepscope Quality Score?
Deepscope rates SXTC's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SXTC?
Deepscope's AI Timing Score for SXTC is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SXTC belong to?
CHINA SXT PHARMACEUTICALS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 2.57
Price
0.31
(13.72%)
Day Change
|
|
|---|
SXTC Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.57 |
| PBV / Sector |
0.50 / 2.65
GREAT
|
| Earning Per Share | 0.10 |
| PE / Sector |
3.05 / 24.99
GREAT
|
| PEG or PE/Growth / Sector |
-0.24 / 0.14
|
| Average 1M Daily Value |
0.24 M
GREAT
|
| Average 1W Daily Value |
0.77 M
GREAT
|
| Yếu tố Kỹ thuật |
|
100% |
| Sức khỏe tài chính |
|
50% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-13 11:12:56 |
| Symbol | SXTC |
| Name | CHINA SXT PHARMACEUTICALS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 4.46 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 10.08 / 10,015.19 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 178 Taidong Road North, Taizhou, China, 225300
Phone: 86 523 8629 8290
Website: https://www.sxtchina.com
Employees: 75
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google